FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “CanaFarma Hemp Products Corp. Announces Lease of 100 Acre Farm”
CanaFarma Hemp Products Corp. (CSE: CNFA) (formerly KYC Technology Inc.) (the “Corporation” or “CanaFarma Hemp”) is pleased to announce that it has signed a lease for 100 acres of farmland in Cato, New York, almost doubling the size of the farm the Company had in 2019.
CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.
Over the past several years, the sale of cannabidiol-based (CBD) products has rapidly increased due to varied, yet successful, legalization efforts. Specifically, in regions such as the U.S. and Canada, consumers have shown a strong demand to purchase such products in retailers, where CBD is sold in various forms such as topicals, beverages, tinctures, and patches. Notably, major retail corporations such as Amazon, Walgreens, and CVS have all decided to sell CBD products in-store as well as on their online platforms. The passage of the U.S. Farm Bill in late 2018, which legalized the commercialization of hemp-derived products, was a major contribution to the acceleration of the market. Shortly after the passage of the bill, retailers throughout the country began to stock up on CBD products as consumers became increasingly inquisitive. At the market’s inception, most consumers generally had little to no knowledge about CBD, except for the fact that it was derived from the cannabis plant. With hemp-derived CBD growing in popularity, in particular within the health, wellness, and anti-pharma segments, the market is on track to grow to USD 23.7 Billion by 2023, according to the Brightfield Group.
Generally, most consumers use CBD products for medicinal purposes. Similarly, retailers are advertising CBD products as therapeutic treatments, however, there is still a large recreational market for the industry. Primarily, most consumers intake CBD to treat a wide range of medical conditions such as chronic pain, mood disorders, neurological disorders, and diabetes. In the healthcare industry, most independent pharmacies have already begun selling CBD products. While there are many ways to consume CBD, the oils marketplace is expected to be the fastest growing segment within the overall CBD sector. For instance, the CBD oil market size will grow by USD 3.52 Billion during the period of 2020 to 2024, according to Technavio. “The 29 U.S. states reporting licensed hemp cultivation acreage total almost half a million acres in combined cultivation land area, which is a massive increase compared to 2018 figures of a total land area barely over 100,000 acres. While there continues to be uncertainty and a healthy amount of confusion around hemp cultivation for CBD production, it is clear that demand is nonetheless continuing to rise across the U.S.,” noted Giadha Aguirre de Carcer, New Frontier Data CEO and Founder. “As states issue more licenses, consumer demand increases, and mass-market retailers such as CVS and Walgreens continue to expand their own product offerings, we expect the FDA may be forced to provide further regulatory clarifications sooner rather than later.”
For more information, please visit: CanaFarma Hemp Products Corp.
For more corporate news on CanaFarma Hemp Products Corp., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.